Kenvue KVUE
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Kenvue (KVUE) Business Model and Operations Summary
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Key Insights
Kenvue (KVUE) Core Market Data and Business Metrics
Latest Closing Price
$23.88Market Cap
$45.67 BillionPrice-Earnings Ratio
44.22Total Outstanding Shares
1.91 Billion SharesTotal Employees
22,000Dividend
$0.20 Per Share QuarterlyIPO Date
May 4, 2023SIC Description
Perfumes, Cosmetics & Other Toilet PreparationsPrimary Exchange
New York Stock ExchangeHeadquarters
1 Kenvue Way, Summit, NJ, 07901
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 29, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities, Continuing | $-1.56 Billion |
| Net Cash Flow | $-312 Million |
| Net Cash Flow From Operating Activities, Continuing | $1.77 Billion |
| Net Cash Flow, Continuing | $-221 Million |
| Net Cash Flow From Investing Activities, Continuing | $-425 Million |
| Net Cash Flow From Operating Activities | $1.77 Billion |
Income Statement
January 1, 2024 to December 29, 2024
| Metric | Value |
|---|---|
| Preferred Stock Dividends And Other Adjustments | $0 |
| Net Income/Loss | $1.03 Billion |
| Income/Loss From Continuing Operations After Tax | $1.03 Billion |
| Income/Loss From Continuing Operations Before Tax | $1.42 Billion |
| Income Tax Expense/Benefit, Deferred | $-285 Million |
| Operating Expenses | $7.12 Billion |
Comprehensive Income
January 1, 2024 to December 29, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $261 Million |
| Comprehensive Income/Loss Attributable To Parent | $261 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $-769 Million |
| Other Comprehensive Income/Loss Attributable To Parent | $-769 Million |
Balance Sheet
January 1, 2024 to December 29, 2024
| Metric | Value |
|---|---|
| Assets | $25.60 Billion |
| Current Liabilities | $5.74 Billion |
| Other Current Assets | $3.93 Billion |
| Noncurrent Assets | $20.08 Billion |
| Wages | $325 Million |
| Current Assets | $5.53 Billion |
Historical Dividends
Current dividend: $0.20 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Jan 16, 2025 | Feb 26, 2025 | Feb 12, 2025 | $0.205 | Quarterly |
| Oct 17, 2024 | Nov 27, 2024 | Nov 13, 2024 | $0.205 | Quarterly |
| Jul 25, 2024 | Aug 28, 2024 | Aug 14, 2024 | $0.205 | Quarterly |
| Apr 25, 2024 | May 22, 2024 | May 8, 2024 | $0.2 | Quarterly |
| Jan 25, 2024 | Feb 28, 2024 | Feb 14, 2024 | $0.2 | Quarterly |
| Oct 26, 2023 | Nov 22, 2023 | Nov 8, 2023 | $0.2 | Quarterly |